Bio-Rad Laboratories S.R.L.

Segrate, Lombardia Part of Bio-Rad Laboratories, Inc.

UEI
QNR9KXU1K1J5
CAGE
A7810
Primary NAICS
423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
SAM.gov registration
Active through

Company facts

FY2025 rankings

Its parent company, BIO - RAD Laboratories Gesellschaft MIT Beschraenkter Haftung, ranks:

and 6 more

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
Via Benvenuto Cellini, 18A, 20054 Segrate MI, Italy
Website
bio-rad.com
Founded
1952
Employees
5K-10K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $40,847
FY2025 $40,167
FY2024 $42,015
FY2023 $41,633

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Defense Health Agency $40,847

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Bio-Rad Laboratories S.R.L., an Italian subsidiary of Bio-Rad Laboratories, Inc., supplies laboratory diagnostic consumables and analyzer reagents to the Defense Health Agency and Department of the Navy as a prime contractor on full-and-open competitive federal contracts with no set-aside designations. The company operates exclusively as a prime vendor with no subcontract footprint and holds two active indefinite delivery contracts (IDCs) with the Defense Health Agency totaling $324 thousand in ceiling value, extending through July 2030.

Bio-Rad Laboratories S.R.L. is headquartered in Segrate, Milan, Italy, and operates as a for-profit manufacturer of goods under the parent entity Bio-Rad Laboratories, Inc. (Hercules, California). The subsidiary competes on full-and-open contract vehicles without set-aside eligibility, characteristic of its parent's large-business posture. Federal work centers on NAICS codes spanning surgical and medical instrument manufacturing, surgical appliance and supplies manufacturing, and in-vitro diagnostic substance manufacturing, with primary PSC coding under Drugs and Biologicals and In Vitro Diagnostic Substances.

The vendor's federal customer base concentrates heavily on overseas military medical operations. The Defense Health Agency accounts for 31 awards totaling $523 thousand (96% of combined potential value), while the Department of the Navy Bureau of Medicine and Surgery places 33 awards worth $381 thousand. The remaining customer set — Department of Health and Human Services National Institutes of Health components, National Cancer Institute, and National Human Genome Research Institute — comprises less than 4 percent of awards. Defense Health Agency work dominates the current pipeline and dollar concentration despite Navy's higher award count; the agency's awards are larger on average.

Bio-Rad Laboratories S.R.L. holds two active IDCs with the Defense Health Agency: the primary vehicle (N6817122D2007, $236 thousand ceiling, expiring September 2027) has generated 18 task orders totaling $127 thousand, and a secondary contract designated for Control Liquidchek supplies (N6817124F2031, $87.9 thousand ceiling, expiring July 2030) anchors commodity-specific procurement. A third legacy IDC (N6817118D2002, $143 thousand combined value across 14 task orders) remains on the source data. Task orders under these vehicles procure immunochemistry and chemistry analyzer consumables (Vitros 5600 and Vitros 350 systems), hematology controls, immunoassay controls, drugs of abuse testing kits, and laboratory control materials in support of U.S. Naval Hospital Sigonella and Naval Medical Research Center Sigonella in Sicily. Recent representative awards include a $6.4 thousand March 2026 delivery order for Vitros immunochemistry and chemistry analyzer consumables at Naval Hospital Sigonella, a $7.7 thousand January 2026 order for toxicology and chemistry testing supplies at Naval Medical Research Center Sigonella, and a $14.7 thousand December 2024 delivery order for laboratory supplies at the same facility.

Activity has grown modestly — four awards in 2022 to eight in 2025 — with two awards recorded in 2026 year-to-date. Combined potential value across the 73-award portfolio totals $1 million, with $555 thousand obligated (54 percent), reflecting the small unit-purchase posture of overseas military medical supply orders. The vendor has maintained consistent performance under Defense Health Agency contracts since at least 2013, according to award summaries, and performance occurs entirely in Italy at the contracting subsidiary's location and at the naval medical facilities it supplies.

Quick answers

Is Bio-Rad Laboratories S.R.L. registered in SAM.gov?

Yes. Bio-Rad Laboratories S.R.L.'s SAM.gov registration is active through August 25, 2027.

How much has Bio-Rad Laboratories S.R.L. received in federal contracts?

Federal contracts obligated $40,167 to Bio-Rad Laboratories S.R.L. in fiscal year 2025 and $164,662 in fiscal years 2023 through 2027.

How does Bio-Rad Laboratories S.R.L. rank among federal contractors?

Bio-Rad Laboratories S.R.L.'s parent company, BIO - RAD Laboratories Gesellschaft MIT Beschraenkter Haftung, ranked #23 in NAICS 325413, #25 in PSC N066 and #26 in PSC W066 in FY2025.

What is Bio-Rad Laboratories S.R.L.'s most recent federal award?

Bio-Rad Laboratories S.R.L.'s most recent federal contract award is Biorad delivery order 20 (N6817126FS038), from Naval Supply Systems Command (Navy), on May 29, 2026.

On GovTribe

See Bio-Rad Laboratories S.R.L.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors